XERS Xeris Biopharma Holdings, Inc.

2mon ago, source: Seeking Alpha

Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies in Illinois. The company offers Gvoke, a ready-to-use liquid-stable glucagon for ...

Xeris Biopharma Holdings Inc (XERS) Stock: What the Analysts are Saying

8d ago, source: newsheater

Opinions on the stock are mixed, with 2 analysts rating it as a “buy,” 2 as “overweight,” 0 as “hold,” and 0 as “sell.” The public float for XERS is 125.56M, and at present, short sellers hold a 7.16% ...

Xeris Biopharma Holdings, Inc.'s (NASDAQ:XERS) top owners are retail investors with 51% stake, while 45% is held by institutions

20d ago, source: Yahoo Finance

Of course, the future is what really matters. We note that hedge funds don't have a meaningful investment in Xeris Biopharma Holdings. BlackRock, Inc. is currently the company's largest ...

Xeris Biopharma Holdings Stock (NASDAQ:XERS), Analyst Ratings, Price Targets, Predictions

28d ago, source: Benzinga.com

$1.80 122.22% HC Wainwright & Co.

Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

22d ago, source: Stockhouse

Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of ...

Xeris Biopharma to Participate in the 23rd Annual Needham Virtual Healthcare Conference

23d ago, source: Business Wire

CHICAGO--(BUSINESS WIRE)--Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patients’ lives by developing and commercializing ...

Xeris Pharmaceuticals Inc (XERS)

22d ago, source: Investing

CHICAGO--(BUSINESS WIRE)--Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patient lives by developing and ...

Xeris Biopharma Holdings Inc

6d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Xeris Biopharma Holdings, Inc.'s (NASDAQ:XERS) top owners are retail investors with 51% stake, while 45% is held by institutions

20d ago, source: Yahoo Finance

We note that hedge funds don't have a meaningful investment in Xeris Biopharma Holdings. BlackRock, Inc. is currently the company's largest shareholder with 7.1% of shares outstanding. For context, ...

Xeris Biopharma Holdings Inc (2B30.BE)

9d ago, source: Yahoo Finance

CHICAGO, April 03, 2024--Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patient lives by developing and commercializing ...

Xeris Biopharma Holdings Inc.

24d ago, source: Barron's

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Xeris Biopharma Holdings Inc.

1mon ago, source: Wall Street Journal

1 Day XERS -2.84% DJIA -0.08% Russell 2K -0.19% Health Care/Life Sciences -0.15% ...